Any serious adverse event | ||
---|---|---|
Study | Symptoms | Adverse events/total number of participants |
Altin 2013 | No patients experienced any serious adverse events | 0/221 |
Arabgol 2015 | Severe anorexia | 1/18 |
Ardic 2014 | Serious adverse events | 0/101 |
Arnold 2004 | Serious adverse events | 3/89 |
Arnold 2010 | Acute depression and suicide attempt | 1/150 |
Ashkenasi 2011 | Hallucinations | 1/26 |
Berek 2011 | Serious adverse events | 4/822 |
Cherland 1999 | Serious adverse events | 13/98 |
Chou 2012b | Serious adverse events | 0/230 |
Cortese 2015 | Serious adverse events | 64/1426 |
Davari‐Ashtiani 2010 | Serious adverse events | 0/16 |
Dittmann 2014 | Serious adverse events | 0/247 |
Döpfner 2011a, OBSEER | Serious adverse events | 21/777 |
Döpfner 2011b | Serious adverse events | 38/822 |
Findling 2009 | Serious adverse events | 3/157 |
Germinario 2013 | Serious adverse events | 7/1098 |
Gerwe 2009 | Serious adverse events | 2/263 |
Haertling 2015 | Serious adverse events | 3/239 |
Hammerness 2009 | Participants affected or at risk | 5/57 |
Hammerness 2012 | Serious adverse events | 0/10 |
Hulvershorn 2012 | Serious adverse events | 0/25 |
Jafarinia 2012 | Serious adverse events | 0/20 |
Jensen 1999 (MTA) | Serious adverse events | 1/245 |
Kemner 2005 (FOCUS) | Sudden death | 0/850 |
Kim 2011 | Serious adverse events | 0/97 |
Lakic 2012 | Strong depressive symptoms | 1/68 |
Lee 2014 | Serious adverse events | 542/4055 |
Li 2011 | Serious adverse events | 0/36 |
Maayan 2009 | Serious adverse events | 0/8 |
McCarthy 2009 | Sudden death | 5/5351 |
McCracken 2016 | Serious adverse events | 0/61 |
Mohammadi 2004 | Serious adverse events | 3/116 |
Pierce 2010 | Serious adverse events | 0/71 |
Remschmidt 2005 | Serious adverse events | 4/89 |
Schmidt 2002 | Generalized tonic‐clonic seizure | 1/124 |
Schulz 2010 | Serious adverse events | 0/145 |
Shin 2016 | Serious adverse events | 1224/123,636 |
Sobanski 2013 | Serious adverse events | 8/347 |
Steele 2006 | Serious adverse events | 0/73 |
Su 2015 | Serious adverse events | 0/239 |
Valdizán Usón 2013 | Serious adverse events | 0/689 |
Warshaw 2010 | Serious adverse events | 0/260 |
Weiss 2007 | Serious adverse events | 0/79 |
Wigal 2011 | Serious adverse events | 0/31 |
Wigal 2013 | Serious adverse events | 0/39 |
Wigal 2015 | Serious adverse events | 1/200 |
Wilens 2006 | Serious adverse events | 1/87 |
Wilens 2008 | Serious adverse events | 0/127 |
Winterstein 2009 | Serious adverse events | 171/18,238 |
Zheng 2015 | Serious adverse events | 0/149 |